vilaprisan: Clinical Trials

3 trials of vilaprisan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow vilaprisan: new trials by email Literature Review of vilaprisan trials Research Report on vilaprisan

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Vilaprisan (BAY1002670), Matching Placebo - Endometriosis
Phase 2TerminatedBayer82018-07-042022-05-04
Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids
Vilaprisan (BAY1002670), Vilaprisan (BAY1002670, Ulipristal - Leiomyoma
Phase 2CompletedBayer1202015-06-012016-11-22
Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap
BAY1002670, Placebo - Leiomyoma
Phase 2CompletedBayer3092014-05-152017-12-08

Conditions studied

Leiomyoma (2)  ·  Endometriosis (1)  ·  Menorrhagia (1)

Sponsors

Bayer (3)

Countries

Czechia (3)  ·  Finland (3)  ·  Austria (2)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Japan (2)  ·  Norway (2)  ·  Poland (2)  ·  Spain (2)  ·  Sweden (2)  ·  United States (2)

Results publications

PMID 30527839, PMID 30682081, PMID 32559602, PMID 38983729

NIH funding

2014 (1)